Imperial College London Diabetes Centre (ICLDC), part of the M42 group, is a state-of-the-art outpatient facility that specialises in diabetes treatment, research, training, and public health awareness. With nearly two decades of excellence, the Centre has gained international renown for its holistic approach to the treatment of diabetes and related complications that enables patients to receive the full spectrum of care they need in one place.
With more than 80 diabetes professionals and endocrinologists under one roof, ICLDC offers best-in-class medical attention from first diagnosis to disease management across 11 specialist practice areas including adult and paediatric endocrinology, treatment of metabolic and electrolyte disorders, pre-and post-bariatric surgery care, heart disease prevention, nutritional advice, diabetes education services, ophthalmology, nephrology, and podiatry.
ICLDC was established in 2006 in Abu Dhabi by Mubadala in partnership with the UK’s Imperial College London to address the growing demand for diabetes care in the UAE. The centre operates multiple facilities across Abu Dhabi as well as a satellite clinic at Mubadala Health Dubai, touching the lives of more than one million people through patient-centric programmes and public health initiatives.
ICLDC holds the Joint Commission International (JCI) Clinical Care Program Certification in Outpatient Diabetes Management and JCI Accreditation for Ambulatory Care.
For more information, visit: www.icldc.ae